Deca

Deca

fluphenazine

Manufacturer:

Atlantic Lab

Distributor:

Atlantic Pharma
Concise Prescribing Info
Contents
Fluphenazine decanoate
Indications/Uses
Management of manifestations of schizophrenia.
Dosage/Direction for Use
0.5-1 mL every 2-5 wk.
Contraindications
Bone marrow depression, comatose states, severe depression.
Special Precautions
Elderly, debilitated. Impaired liver or kidney function, CV or resp disorders, parkinsonism, diabetes, pheochromocytoma, epilepsy, glaucoma. May impair temp regulatory mechanism.
Adverse Reactions
Drowsiness, dependence, antimuscarinic effects, insomnia, depression, convulsions, agitation, tachycardia, postural hypotension, allergic reactions, agranulocytosis, tardive dyskinesia, depressive reactions.
Drug Interactions
Alcohol, CNS depressants, clonidine.
MIMS Class
ATC Classification
N05AB02 - fluphenazine ; Belongs to the class of phenothiazine antipsychotics with piperazine structure.
Presentation/Packing
Form
Deca inj 25 mg/mL
Packing/Price
1 mL x 1's
Form
Deca inj 50 mg/2 mL
Packing/Price
2 mL x 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in